This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Investors
Financial Statements
31 July 2024 | Three Months Ended July 31, 2024 | Financials | MD&A |
30 April 2024 | Years Ended April 30, 2024 and 2023 | Financials | MD&A |
31 January 2024 | Nine Months Ended January 31, 2024 | Financials | MD&A |
31 October 2023 | Six Months Ended October 31, 2023 | Financials | MD&A |
31 July 2023 | Three Months Ended July 31, 2023 | Financials | MD&A |
30 April 2023 | Years Ended April 30, 2023 and 2022 | Financials | MD&A |
31 January 2023 | Nine Months Ended January 31, 2023 | Financials | MD&A |
31 October 2022 | Six Months Ended October 31, 2022 | Financials | MD&A |
31 July 2022 | Three Months Ended July 31, 2022 | Financials | MD&A |
30 April 2022 | Years Ended April 30, 2022 and 2021 | Financials | MD&A |
31 January 2022 | Nine Months Ended January 31, 2022 | Financials | MD&A |
31 October 2021 | Six Months Ended October 31, 2021 | Financials | MD&A |
31 July 2021 | Three Months Ended July 31, 2021 | Financials | MD&A |
30 April 2021 | Years Ended April 30, 2021 and 2020 | Financials | MD&A |
31 January 2021 | Nine Months Ended January 31, 2021 | Financials | MD&A |
31 October 2020 | Six Months Ended October 31, 2020 | Financials | MD&A |
31 July 2020 | Three Months Ended July 31, 2020 | Financials | MD&A |
30 April 2020 | Years Ended April 30, 2020 and 2019 | Financials | MD&A |
31 January 2020 | Nine Months Ended January 31, 2020 | Financials | MD&A |